![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 11, 7443-7446, March 17, 2000
From the Departments of Physiology and Biochemistry and Molecular
Biology, Colorado State University, Ft.
Collins, Colorado 80523
Ion channel targeting within neuronal and muscle
membranes is an important determinant of electrical excitability.
Recent evidence suggests that there exists within the membrane
specialized microdomains commonly referred to as lipid rafts. These
domains are enriched in cholesterol and sphingolipids and concentrate a
number of signal transduction proteins such as nitric-oxide synthase,
ligand-gated receptors, and multiple protein kinases. Here, we
demonstrate that the voltage-gated K+ channel Kv2.1,
but not Kv4.2, targets to lipid rafts in both heterologous expression
systems and rat brain. The Kv2.1 association with lipid rafts does not
appear to involve caveolin. Depletion of cellular cholesterol alters
the buoyancy of the Kv2.1 associated rafts and shifts the midpoint of
Kv2.1 inactivation by nearly 40 mV without affecting peak current
density or channel activation. The differential targeting of Kv
channels to lipid rafts represents a novel mechanism both for the
subcellular sorting of K+ channels to regions of the
membrane rich in signaling complexes and for modulating channel
properties via alterations in lipid content.
The subcellular localization of ion channels is necessary for
proper electrical signaling. In cardiac and skeletal myocytes, ion
channels show a differential surface distribution (1, 2). Within the
brain, voltage-gated K+ (Kv) channels often show not only
polarized sorting to either axons or dendrites, but also
isoform-specific localization within dendrites alone. Thus, there
exists specific sorting mechanisms for restricting lateral distribution
within a given membrane domain (3). One physiological consequence for
such specific localization is that it places various signal
transduction molecules near their ion channel substrates (4). Several
families of intracellular proteins, PDZs and AKAPs, have been shown to
cluster both ion channels and modulatory signaling enzymes. Indeed,
great emphasis has been placed on the role of PDZ proteins such as
PSD-95 in the targeting and localization of ion channels and
neurotransmitter receptors (5). In contrast, the role of membrane
lipids in differential targeting and integration of ion channels within the plane of the plasma membrane has not been addressed.
Recent advances in the study of cell membrane structure have led to the
emerging idea that microdomains exist within the fluid bilayer of the
plasma membrane. These dynamic structures, termed lipid rafts, are rich
in tightly packed sphingolipids and cholesterol (6). The rafts, which
are present in both excitable and non-excitable cells, localize a
number of membrane proteins, including multiple signal transduction
molecules, while excluding others (7). Different types of rafts are
likely to exist based on the presence of specific marker proteins and
ultrastructure data (8). Caveolae represent one well studied
subpopulation of lipid raft having an invaginated morphology and
containing the scaffolding protein, caveolin, which interacts directly
with several intracellular proteins (7, 9-12). Here, we demonstrate
that Kv2.1 K+ channels target to a non-caveolar lipid raft
in both transfected cells and brain, whereas the Kv4.2 channel does
not. In addition, cholesterol depletion dramatically alters Kv2.1
inactivation, while having no effect on Kv4.2. Thus, lipid raft
association represents a new targeting mechanism for Kv channel
localization that is based on protein-lipid interactions.
Materials--
Anti-actin and anti-tubulin antibodies were
purchased from Sigma. The anti-rat Na,K-ATPase Raft Isolation--
Low density, Triton-insoluble complexes were
isolated as described by Lisanti and co-workers (13) from mouse
L-cells stably expressing either rat Kv2.1 or Kv4.2
channels (14, 15). Briefly, cells from 10 100-mm near confluent culture
dishes were homogenized in 1 ml of 1% Triton X-100 and sucrose added
to a final concentration of 40%. A 5-30% linear sucrose gradient was
layered on top of this detergent extract followed by
ultracentrifugation (39,000 rpm) for 18-20 h at 4 °C in a Beckman
SW41 rotor. Gradient fractions (600 µl) were collected from the top
and analyzed by Western blot. Rat brain raft isolation used one brain
(approximately 0.6 g) homogenized in 10 ml
Mes1-buffered saline (25 mmol/liter Mes, pH 6.5, 0.15 mol/liter NaCl) containing 1% Triton
X-100, 1 mmol/liter phenylmethylsulfonyl fluoride, 2 µg/ml pepstatin,
and leupeptin using 18 strokes of a loose fitting dounce homogenizer.
This homogenate was then centrifuged at 3000 rpm, 4 °C for 15 min to
sediment debris. The supernatant was processed as described above (13).
The detergent-free raft isolations were performed as described
previously (16). Basically, this protocol introduces a sonication step
to disrupt the cellular membranes followed by subcellular fraction on a
discontinuous 5-35% sucrose gradient in a buffer containing sodium
carbonate, pH 11.0. Triton solubility experiments were performed on
cells homogenized in Mes-buffered saline containing 1% Triton X-100 with or without a 0.5% saponin pretreatment for 30 min at 4 °C. The
detergent-soluble (lysate) and -insoluble fractions (pellet) were
separated by centrifugation (14,000 rpm, for 30 min at 4 °C) and
analyzed by immunoblotting.
Immunostaining--
Immunostaining of cells was performed using
anti-Kv2.1 polyclonal antibodies and/or anti-caveolin antibodies as
described previously (1). Demecolcine (0.1 µg/ml; Sigma) was
dissolved in the culture medium. The bound anti-caveolin antibody was
detected with BODIPY-conjugated streptavidin (green), and the Kv2.1
antibody was detected with CY3-conjugated streptavidin (red).
Fluorescent signals were collected using a Nikon E800 microscope
equipped with standard epifluorescence and a Princeton Instruments CCD camera.
Electrophysiology--
Electrophysiological recordings and data
analysis were made as described previously using the whole-cell
configuration of the patch clamp technique (14). The steady-state
inactivation was measured using a 10 s. conditioning pulse to
various potentials followed by 500-ms test steps to +40 mV. Kv2.1
exhibits complex inactivation kinetics including a U-shaped voltage
dependence and excessive cumulative inactivation (17). Therefore, we
measured only the voltage dependence of inactivation over the range of potentials (
Additional details are presented in the figure legends.
Kv2.1, but Not Kv4.2, Is Localized to Lipid Rafts in Transfected
Fibroblasts--
Kv2.1 is a delayed rectifier K+ current
that inactivates very slowly over a period of seconds. In contrast,
Kv4.2 encodes for a transient current that activates and inactivates
within milliseconds. Kv2.1 and Kv4.2 stably transfected mouse Ltk Kv2.1 Is Localized in Non-caveolar Lipid Rafts--
Dual
immunostaining of L-cells expressing Kv2.1 with
anti-channel and anti-caveolin antibodies revealed only partial overlap of the two proteins (Fig. 2). Although
both caveolin (Fig. 2B) and Kv2.1 (Fig. 2C)
display punctate cell surface staining, there is incomplete
colocalization (Fig. 2, D and E), suggesting that Kv2.1 is in a lipid raft that does not contain caveolin. To better resolve this issue, a pharmacological intervention was used to disrupt
the normal cell surface distribution of caveolae. Previous reports have
suggested a role for microtubules in the maintenance and transport of
caveolae with microtubule disruption resulting in caveolin
internalization (18, 19). L-cells stably expressing Kv2.1
were immunostained with anti-Kv2.1 and caveolin antibodies before (Fig.
3, B and F) and
after (Fig. 3, D and H) treatment with
demecolcine, to disrupt microtubule organization. In the treated, and
thus rounded cells (compare Fig. 3, A and C and
E and G), caveolin was retracted from the cell
surface (compare Fig. 3, F and H), consistent
with previous reports (19). However, demecolcine treatment did not
alter the cell surface localization of Kv2.1 channel protein (Fig.
3D). Therefore, Kv2.1 channel protein does not follow
caveolin redistribution after microtubule disruption. Consistent with
these results, immunoprecipitation of caveolin failed to demonstrate an
association between Kv2.1 and caveolin in either the L-cell
system or rat heart, which expresses both Kv2.1 and caveolin (data not
shown). Taken together, these data strongly suggest that Kv2.1 is
associated with a non-caveolar lipid raft.
Kv2.1, but Not Kv4.2, Is Localized to Lipid Rafts in Rat
Brain--
The issue of Kv channel targeting to lipid rafts in
vivo was addressed in the brain where the subcellular distribution
and polarized sorting of voltage-gated K+ channels is
critical for neural excitability. In addition, both Kv2.1 and Kv4.2
have previously been localized to neurons where they display a very
different and restricted distribution within the lateral plane of the
neuronal surface (20-22). Sucrose density gradient fractionation of
Triton X-100 extracted rat brain lysates revealed that nearly all of
the Kv2.1 was found in low density membrane fractions (Fig.
4). In contrast, Kv4.2 was detected only in the high density fractions at the bottom of the gradient. Thus, differential targeting to lipid rafts is not an artifact of either the
L-cell or HEK 293 expression systems. In agreement with an association with non-caveolar rafts, caveolin expression is lacking in
neurons where Kv2.1 is concentrated (20, 23).
Depletion of Membrane Cholesterol Alters Kv2.1-containing Raft
Buoyancy and Channel Function--
Given the unique organization of
membrane sphingolipids and cholesterol within lipid rafts, these
structures are sensitive to cholesterol modifying agents (7, 24).
Treatment of cells stably expressing Kv2.1 with 2%
2-hydroxypropyl- Possible Functions of the Lipid Raft-Channel Complex--
Since
rafts often localize signaling proteins such as protein kinase C,
nitric-oxide synthase, tyrosine kinases, Ha-Ras, mitogen-activated protein kinase, glycosylphosphatidylinositol-anchored proteins and
G-proteins, channel/raft association could serve primarily to cluster
signaling molecules with ion channels (9-12). Kv channels are known to
be modulated by activation of various signal transduction pathways and
often contain multiple consensus phosphorylation sites (4). In fact,
Kv2.1 is constitutively tyrosine phosphorylated and physically
associates with tyrosine kinases in Schwann cells (25). Multiple
reports have localized tyrosine kinases to lipid raft microdomains
including those from neuronal plasma membranes (26). Differential
targeting to various lipid raft subpopulations may serve to organize
signaling molecules and their K+ channel substrates. It is
possible that the functional effects of cyclodextrin treatment are a
consequence of kinase disruption as opposed to direct effects of
altered lipid on channel activity.
It is also tempting to hypothesize a possible role for lipid-protein
rafts in the polarized sorting of K+ channels in the brain.
Certainly, this appears to be a mechanism for the polarized sorting of
other neuronal proteins (27-29). Although both channels target to
dendrites, it is clear that even within the dendritic region multiple
plasma membrane subdomains exist (29), for the Kv2.1 and Kv4.2 channels
segregate to somatodendritic and distal regions, respectively (22).
Potential Mechanisms of Channel-Raft Association--
One
obvious question deals with the mechanism of channel targeting to
rafts. The channel could bind raft-associated proteins or it could
directly target to, or interact with, the raft lipid. The cytoplasmic
COOH-terminal domain of Kv2.1 has been implicated in the polarized
sorting and clustering of Kv2.1 in Madin-Darby canine kidney cells (3).
However, preliminary results based on truncation mutants of Kv2.1
suggest that neither the amino or carboxyl terminus is necessary for
targeting to lipid rafts (data not shown). This finding is consistent
with reports that transmembrane regions of integral membrane proteins
may contain the information that determine raft association (30).
An alternative mechanism for channel-raft association may involve the
channel binding to other raft-associated proteins. One candidate is
PSD-95, which has been reported to associate with low density lipid
rafts in both COS cells and rat brain (31). In addition, protein-lipid
interactions are necessary for clustering of this PDZ protein at the
synapse (32). Therefore, raft-bound PDZ proteins could localize ion
channels to raft domains. However, Kv2.1 does not contain standard PDZ
binding sequences nor does it interact with PSD-95 (3). Even if it did
contain a PDZ binding site, the Kv2.1 truncation mentioned above still
targets to rafts. In addition, glutamate receptors bind PDZ proteins
but are not raft associated (26). Thus, PDZ proteins are not likely to
be responsible for raft localization. Recent work from the Clapham laboratory (33) indicates that PSD-95, when expressed in slices of rat
cortex, only targets to axons in the presence of Kv1.4 channel
coexpression. Thus, the ion channel, or another protein which
recognizes the PSD-95-channel complex, is responsible for localizing
PSD-95 to the axon. It is tempting to speculate that localization of
channels to rafts is part of a mechanism by which PDZ proteins are
themselves localized. Another candidate protein for targeting
K+ channels to rafts is the K+ channel beta
subunit. This protein has been implicated in channel association with
the cytoskeleton. However, Kv2.1 does not associate with the Kvbeta 2.1 subunit present in the L-cell expression system (data not
shown), making the Conclusion--
This report is the first description of ion
channels localizing to lipid microdomains and provides a dramatic
example of the differential targeting of protein isoforms to lipid
rafts. Although progress has been made in identifying elements involved
in channel targeting, clustering, and anchoring, it is not yet clear
how the number and location of channel complexes within the plane of
the membrane are determined (32). Our data indicate that protein-lipid
interactions should be considered as a mechanism of Kv channel
localization. The finding that cyclodextrin treatment shifts
steady-state inactivation in the hyperpolarizing direction by more than
30 mV suggests that alteration of membrane lipid, either by disease
(35) or the clinical use of lipid-lowering drugs, can affect membrane
excitability by altering the function of raft-localized channels.
We thank Barbara Birks for technical
assistance and Drs. Kurt Beam and Kathy Partin for review of this
manuscript. Dr. Peter Backx kindly provided the Kv4.2 antibody.
*
This work was supported by National Institutes of Health
Grant HL-49330 (to M. M. T.) and National Institutes of
Health Postdoctoral Fellowship 1F32HD08496-01 (to J. R. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The abbreviation used is:
Mes, 4-morpholineethanesulfonic acid.
ACCELERATED PUBLICATION
Differential Targeting of Shaker-like Potassium Channels
to Lipid Rafts*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
1 subunit antibody
and the polyclonal anti-Kv2.1 antibody were purchased from Upstate
Biotechnology (Lake Placid, NY). Anti-caveolin polyclonal antibody,
which recognizes caveolin isoforms 1, 2, and 3, was obtained from
Transduction Laboratories (Lexington, KY). Saponin and
2-hydroxypropyl-
-cyclodextrin were purchased from Sigma.
100 to +10 mV), which show maximal inactivation.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
cells (L-cells) showed high levels of cell surface
expression as evidenced by the nanoampere current recordings (Fig.
1A). Kv2.1 is Triton
X-100-insoluble when transfected in Madin-Darby canine kidney cells,
suggesting that an interaction with the detergent-insoluble
cytoskeleton may be necessary for proper Kv2.1 localization (3). As
shown in Fig. 1B, Kv2.1 stably expressed in mouse
L-cells was also insoluble in 1% Triton X-100. However,
when these cells were pretreated with 0.5% saponin, a detergent that
complexes with membrane cholesterol, Kv2.1 was nearly completely
solubilized in Triton X-100, suggesting that cholesterol is required
for the detergent resistance of Kv2.1. Similar results were obtained
for the lipid raft marker protein, caveolin (Fig. 1B).
Saponin alone did not solubilize either Kv2.1 or caveolin (data not
shown). Next, we isolated low density, Triton X-100-insoluble complexes
from cells stably expressing Kv2.1 and Kv4.2. Western blot analysis of
sucrose gradient fractions probed with anti-Kv2.1 antibodies
demonstrated that a majority of Kv2.1 floats in a low density,
Triton-insoluble fraction together with caveolin. The small percentage
of Kv2.1 in the non-raft fractions most likely represents overexpressed
intracellular protein. The percentage of non-raft channel varied
between clonal cell lines and correlated with the amount of
intracellular protein as determined by immunostaining (data not shown).
In contrast to Kv2.1, Kv4.2 was excluded from the low density fractions
and found exclusively at the bottom of the gradient (Fig.
1C). Additionally, the endogenous Na+/K+ ATPase, actin and tubulin, were all
found in non-raft fractions (Fig. 1C). However, with very
long exposure times, a small percentage of the immunoreactive actin
appeared in the low density fractions. The differential association of
Kv2.1 and Kv4.2 with the light membrane fractions was also found to be
true in transfected human embryonic kidney cells (HEK), demonstrating
that this is not limited to fibroblasts (data not shown). The
localization of Kv2.1 and caveolin to lipid rafts in the transfected
L-cells was also confirmed using a detergent-free method of
raft isolation (Fig. 1D) (16). This technique uses
sonication to disrupt the membrane followed by alkaline extraction and
avoids the potential issue of a detergent-induced artifactual
association of Kv2.1 and light membrane fractions.

View larger version (31K):
[in a new window]
Fig. 1.
Kv channels differentially target to lipid
rafts in heterologous expression systems. A,
representative currents recorded from cell surface during 10 mV step
depolarizations (holding potential,
80 mV) to +60 mV in mouse Ltk
cells stably expressing either Kv2.1 (top) or Kv4.2
(bottom). B, the effect of saponin on the Triton
solubility of Kv2.1 and caveolin. Cell lysates were incubated with (+)
or without (
) 0.5% saponin on ice for 30 min. They were then
extracted with 1% Triton X-100 and subjected to centrifugation as
described under "Experimental Procedures." Detergent-soluble
protein in the lysate (L) and insoluble protein in the
pellet (P) were analyzed by Western blot. C,
detergent-based isolation of lipid rafts. Sucrose density gradient
centrifugation of 1% Triton X-100-solubilized extracts from cells
stably expressing Kv channel protein were analyzed by Western blot. The
immunoblots show low density, raft-associated distribution of Kv2.1 and
caveolin in contrast to the high density, non-floating distribution of
Kv4.2, endogenous Na+/K+ ATPase, actin, and
tubulin. D, detergent-free raft isolation with cells stably
expressing Kv2.1. Both Kv2.1 and caveolin are found exclusively in the
low density, raft-associated fractions.

View larger version (33K):
[in a new window]
Fig. 2.
Kv2.1 channel localization shows incomplete
overlap with caveolin. Dual immunostaining of Kv2.1 transfected
L-cells for both the channel and endogenous caveolin
revealed partial colocalization. A, phase micrograph of
mouse L-cell. The detection of bound anti-caveolin antibody
(1:500) and anti-Kv2.1 (1:500) are shown individually in B
and C, respectively. An overlay of the two images is shown
in D. The white box represents enlarged area
shown in E. Arrows point to regions of cells that
show cell surface Kv2.1 channel but no caveolin.

View larger version (72K):
[in a new window]
Fig. 3.
Kv2.1 channel protein does not follow
caveolin redistribution after microtubule disruption.
Immunofluorescence localization of Kv2.1 shows cell surface staining
that is not altered with 24 h of colcemide (0.1 µg/ml) treatment
at 37 °C (compare B and D). However, the
punctate cell surface distribution of caveolin was retracted from the
cell surface following colcemide treatment (compare F and
H). A, C, F, and
G show the corresponding phase images.

View larger version (15K):
[in a new window]
Fig. 4.
Kv channels differentially target to lipid
rafts in rat brain. Sucrose density gradient fractions of 1%
Triton X-100 extracted rat brain lysates were analyzed for Kv2.1 and
Kv4.2 immunoreactivity. Kv2.1 floats in a low density lipid fraction
whereas Kv4.2 is found at the bottom of the gradient in the non-raft
fractions.
-cyclodextrin for 1 h altered the buoyancy of
the Kv2.1 channel containing rafts (Fig.
5A), with the Kv2.1 protein
shifted toward higher density fractions following treatment with the
cholesterol-binding drug. These cholesterol-depleted cells were assayed
by voltage clamp to assess Kv2.1 channel function. The current density
and activation kinetics were not affected by cyclodextrin treatment
(compare Fig. 5, B and C). Voltage sensitivity
was also unaltered as shown in Fig. 5D. However,
cyclodextrin significantly altered the steady-state inactivation of
Kv2.1 as evidenced by a 36-mV hyperpolarizing shift in the inactivation
curve (Fig. 5E). The V1/2 for
inactivation of control and cyclodextrin-treated cells was
15.7 ± 0.59 and
51.6 ± 0.44, respectively. The drug effect was not
due to a direct interaction with channel protein because acute application of cyclodextrin in the bath solution did not affect channel
function. Therefore, cyclodextrin treatment did not non-selectively modify channel gating or cell surface expression but rather
specifically altered inactivation. Treatment of cells stably expressing
Kv4.2 showed no observable effect (data not shown). These data show that altering raft structure significantly affects the function of
raft-associated channels. Such a large shift in steady-state inactivation can lead to a dramatic shift in both resting potential and/or action potential duration.

View larger version (20K):
[in a new window]
Fig. 5.
Depletion of membrane cholesterol alters
Kv2.1 raft buoyant density and channel function. A,
immunoblots of sucrose density gradient fractions of 1% Triton X-100
solubilized extracts from Kv2.1 expressing cells, with or without
exposure to 2% 2-hydroxypropyl-
-cyclodextrin dissolved in the
culture medium for 1 h at 37 °C. B, current record
from control cells (
80 mV holding potential; step +60 mV) stably
expressing Kv2.1. C, current from cell treated with 2%
2-hydroxypropyl-
-cyclodextrin for 1 h at 37 °C.
D, plot showing the voltage dependence of Kv2.1 current
activation, as determined from the magnitude of the tail currents, for
control (
, n = 13) and cyclodextrin treated (
,
n = 9) cells. E, plot showing the voltage
dependence of Kv2.1 current inactivation determined using the double
pulse protocol described under "Experimental Procedures" (control
(
), n = 12; cyclodextrin-treated (
),
n = 5). Increasing the concentration of cyclodextrin or
extending the incubation time made the cells very difficult to patch
clamp.
subunit a poor candidate (34). Additional
mutagenesis experiments are necessary to determine a potential raft
association signal within the channel.
![]()
ACKNOWLEDGEMENT
![]()
FOOTNOTES
To whom correspondence should be addressed: Dept. of Physiology,
Colorado State University, Ft. Collins, CO 80523. Tel.: 970-491-3484; Fax: 970-491-7569; E-mail: tamkunmm@lamar.colostate.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
1.
Mays, D. J.,
Foose, J. M.,
Philipson, L. H.,
and Tamkun, M. M.
(1995)
J. Clin. Invest.
96,
282-292
2.
Jorgensen, A. O.,
Shen, A. C.,
Arnold, W.,
Leung, A. T.,
and Campbell, K. P.
(1989)
J. Cell Biol.
109,
135-147 3.
Scannevin, R. H.,
Murakoshi, H.,
Rhodes, K. J.,
and Trimmer, J. S.
(1996)
J. Cell Biol.
135,
1619-1632 4.
Jonas, E. A.,
and Kaczmarek, L. K.
(1996)
Curr. Opin. Neurobiol.
6,
318-323[CrossRef][Medline]
[Order article via Infotrieve]
5.
Sheng, M.
(1996)
Neuron
17,
575-578[CrossRef][Medline]
[Order article via Infotrieve]
6.
Simons, K.,
and Ikonen, E.
(1997)
Nature
387,
569-572[CrossRef][Medline]
[Order article via Infotrieve]
7.
Harder, T.,
and Simons, K.
(1997)
Curr. Opin. Cell Biol.
9,
534-542[CrossRef][Medline]
[Order article via Infotrieve]
8.
Volonte, D.,
Galbiati, F.,
Li, S.,
Nishiyama, K.,
Okamoto, T.,
and Lisanti, M. P.
(1999)
J. Biol. Chem.
274,
12702-12709 9.
Kurzchalia, T. V.,
and Parton, R. G.
(1999)
Curr. Opin. Cell Biol.
11,
424-431[CrossRef][Medline]
[Order article via Infotrieve]
10.
Anderson, R. G.
(1998)
Annu. Rev. Biochem.
67,
199-225[CrossRef][Medline]
[Order article via Infotrieve]
11.
Okamoto, T.,
Schlegel, A.,
Scherer, P. E.,
and Lisanti, M. P.
(1998)
J. Biol. Chem.
273,
5419-5422 12.
Hooper, N. M.
(1999)
Mol. Membr. Biol.
16,
145-156[CrossRef][Medline]
[Order article via Infotrieve]
13.
Sargiacomo, M.,
Sudol, M.,
Tang, Z.,
and Lisanti, M. P.
(1993)
J. Cell Biol.
122,
789-807 14.
Hulme, J. T.,
Coppock, E. A.,
Felipe, A.,
Martens, J. R.,
and Tamkun, M. M.
(1999)
Circ. Res.
85,
489-497 15.
Fiset, C.,
Clark, R. B.,
Shimoni, Y.,
and Giles, W. R.
(1997)
J. Physiol (Lond.)
500,
51-64[Medline]
[Order article via Infotrieve]
16.
Song, S. K.,
Li, S.,
Okamoto, T.,
Quilliam, L. A.,
Sargiacomo, M.,
and Lisanti, M. P.
(1996)
J. Biol. Chem.
271,
9690-9697 17.
Klemic, K. G.,
Shieh, C. C.,
Kirsch, G. E.,
and Jones, S. W.
(1998)
Biophys. J.
74,
1779-1789 18.
Conrad, P. A.,
Smart, E. J.,
Ying, Y. S.,
Anderson, R. G.,
and Bloom, G. S.
(1995)
J. Cell Biol.
131,
1421-1433 19.
Isshiki, M.,
Ando, J.,
Korenaga, R.,
Kogo, H.,
Fujimoto, T.,
Fujita, T.,
and Kamiya, A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
5009-5014 20.
Trimmer, J. S.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
10764-10768 21.
Sheng, M.,
Tsaur, M. L.,
Jan, Y. N.,
and Jan, L. Y.
(1992)
Neuron
9,
271-284[CrossRef][Medline]
[Order article via Infotrieve]
22.
Maletic-Savatic, M.,
Lenn, N. J.,
and Trimmer, J. S.
(1995)
J. Neurosci.
15,
3840-3851[Abstract]
23.
Ikezu, T.,
Ueda, H.,
Trapp, B. D.,
Nishiyama, K.,
Sha, J. F.,
Volonte, D.,
Galbiati, F.,
Byrd, A. L.,
Bassell, G.,
Serizawa, H.,
Lane, W. S.,
Lisanti, M. P.,
and Okamoto, T.
(1998)
Brain Res.
804,
177-192[CrossRef][Medline]
[Order article via Infotrieve]
24.
Klein, U.,
Gimpl, G.,
and Fahrenholz, F.
(1995)
Biochemistry
34,
13784-13793[CrossRef][Medline]
[Order article via Infotrieve]
25.
Sobko, A.,
Peretz, A.,
and Attali, B.
(1998)
EMBO J.
17,
4723-4734[CrossRef][Medline]
[Order article via Infotrieve]
26.
Wu, C.,
Butz, S.,
Ying, Y.,
and Anderson, R. G.
(1997)
J. Biol. Chem.
272,
3554-3559 27.
Ledesma, M. D.,
Simons, K.,
and Dotti, C. G.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
3966-3971 28.
Dotti, C. G.,
Parton, R. G.,
and Simons, K.
(1991)
Nature
349,
158-161[CrossRef][Medline]
[Order article via Infotrieve]
29.
Colman, D. R.
(1999)
Neuron
23,
649-651[CrossRef][Medline]
[Order article via Infotrieve]
30.
Scheiffele, P.,
Roth, M. G.,
and Simons, K.
(1997)
EMBO J.
16,
5501-5508[CrossRef][Medline]
[Order article via Infotrieve]
31.
Perez, A. S.,
and Bredt, D. S.
(1998)
Neurosci. Lett.
258,
121-123[CrossRef][Medline]
[Order article via Infotrieve]
32.
Craven, S. E.,
El Husseini, A. E.,
and Bredt, D. S.
(1999)
Neuron
22,
497-509[CrossRef][Medline]
[Order article via Infotrieve]
33.
Arnold, D. B.,
and Clapham, D. E.
(1999)
Neuron
23,
149-157[CrossRef][Medline]
[Order article via Infotrieve]
34.
Nakahira, K.,
Shi, G. Y.,
Rhodes, K. J.,
and Trimmer, J. S.
(1996)
J. Biol. Chem.
271,
7084-7089 35.
Masserini, M.,
Palestini, P.,
and Pitto, M.
(1999)
J. Neurochem.
73,
1-11[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. A. Khan, X. O. Mao, S. Banwait, C. M. DerMardirossian, G. M. Bokoch, K. Jin, and D. A. Greenberg Regulation of hypoxic neuronal death signaling by neuroglobin FASEB J, June 1, 2008; 22(6): 1737 - 1747. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Jindal, E. J. Folco, G. X. Liu, and G. Koren Posttranslational modification of voltage-dependent potassium channel Kv1.5: COOH-terminal palmitoylation modulates its biological properties Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2012 - H2021. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vicente, N. Villalonga, M. Calvo, A. Escalada, C. Solsona, C. Soler, M. M. Tamkun, and A. Felipe Kv1.5 Association Modifies Kv1.3 Traffic and Membrane Localization J. Biol. Chem., March 28, 2008; 283(13): 8756 - 8764. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. McEwen, Q. Li, S. Jackson, P. M. Jenkins, and J. R. Martens Caveolin Regulates Kv1.5 Trafficking to Cholesterol-Rich Membrane Microdomains Mol. Pharmacol., March 1, 2008; 73(3): 678 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yuan, R. J. O'Connell, A. Wilson, A. Z. Pietrzykowski, and S. N. Treistman Acute Alcohol Tolerance Is Intrinsic to the BKCa Protein, but Is Modulated by the Lipid Environment J. Biol. Chem., February 22, 2008; 283(8): 5090 - 5098. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. McEwen, S. M. Schumacher, Q. Li, M. D. Benson, J. A. Iniguez-Lluhi, K. M. Van Genderen, and J. R. Martens Rab-GTPase-dependent Endocytic Recycling of KV1.5 in Atrial Myocytes J. Biol. Chem., October 5, 2007; 282(40): 29612 - 29620. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Abi-Char, A. Maguy, A. Coulombe, E. Balse, P. Ratajczak, J.-L. Samuel, S. Nattel, and S. N. Hatem Membrane cholesterol modulates Kv1.5 potassium channel distribution and function in rat cardiomyocytes J. Physiol., August 1, 2007; 582(3): 1205 - 1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Steele, J. Eldstrom, and D. Fedida Mechanisms of cardiac potassium channel trafficking J. Physiol., July 1, 2007; 582(1): 17 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, K. Foster, Q. Li, and J. R. Martens S-acylation regulates Kv1.5 channel surface expression Am J Physiol Cell Physiol, July 1, 2007; 293(1): C152 - C161. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tikku, Y. Epshtein, H. Collins, A. J. Travis, G. H. Rothblat, and I. Levitan Relationship between Kir2.1/Kir2.3 activity and their distributions between cholesterol-rich and cholesterol-poor membrane domains Am J Physiol Cell Physiol, July 1, 2007; 293(1): C440 - C450. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hassinen, V. Paajanen, J. Haverinen, H. Eronen, and M. Vornanen Cloning and expression of cardiac Kir2.1 and Kir2.2 channels in thermally acclimated rainbow trout Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2328 - R2339. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yuan, R. J. O'Connell, R. F. Jacob, R. P. Mason, and S. N. Treistman Regulation of the Gating of BKCa Channel by Lipid Bilayer Thickness J. Biol. Chem., March 9, 2007; 282(10): 7276 - 7286. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kloda, L. Lua, R. Hall, D. J. Adams, and B. Martinac Liposome reconstitution and modulation of recombinant N-methyl-D-aspartate receptor channels by membrane stretch PNAS, January 30, 2007; 104(5): 1540 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Murtazina, O. Kovbasnjuk, M. Donowitz, and X. Li Na+/H+ Exchanger NHE3 Activity and Trafficking Are Lipid Raft-dependent J. Biol. Chem., June 30, 2006; 281(26): 17845 - 17855. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maguy, T. E. Hebert, and S. Nattel Involvement of lipid rafts and caveolae in cardiac ion channel function Cardiovasc Res, March 1, 2006; 69(4): 798 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, S. Chi, M. Liu, W. Yang, T. Wei, Z. Qi, and F. Yang Inhibitory effect of ganglioside GD1b on K+ current in hippocampal neurons and its involvement in apoptosis suppression J. Lipid Res., December 1, 2005; 46(12): 2580 - 2585. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sugama, S. Ohkubo, M. Atsumi, and N. Nakahata Mastoparan Changes the Cellular Localization of G{alpha}q/11 and G{beta} through Its Binding to Ganglioside in Lipid Rafts Mol. Pharmacol., November 1, 2005; 68(5): 1466 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Nerbonne and R. S. Kass Molecular Physiology of Cardiac Repolarization Physiol Rev, October 1, 2005; 85(4): 1205 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Toselli, G. Biella, V. Taglietti, E. Cazzaniga, and M. Parenti Caveolin-1 Expression and Membrane Cholesterol Content Modulate N-Type Calcium Channel Activity in NG108-15 Cells Biophys. J., October 1, 2005; 89(4): 2443 - 2457. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vial and R. J. Evans Disruption of Lipid Rafts Inhibits P2X1 Receptor-mediated Currents and Arterial Vasoconstriction J. Biol. Chem., September 2, 2005; 280(35): 30705 - 30711. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.A. van Gestel, I.A. Brewis, P.R. Ashton, J.B. Helms, J.F. Brouwers, and B.M. Gadella Capacitation-dependent concentration of lipid rafts in the apical ridge head area of porcine sperm cells Mol. Hum. Reprod., August 1, 2005; 11(8): 583 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. S. O'Connell and M. M. Tamkun Targeting of voltage-gated potassium channel isoforms to distinct cell surface microdomains J. Cell Sci., May 15, 2005; 118(10): 2155 - 2166. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Crossthwaite, T. Seebacher, N. Masada, A. Ciruela, K. Dufraux, J. E. Schultz, and D. M. F. Cooper The Cytosolic Domains of Ca2+-sensitive Adenylyl Cyclases Dictate Their Targeting to Plasma Membrane Lipid Rafts J. Biol. Chem., February 25, 2005; 280(8): 6380 - 6391. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. G. Romanenko, Y. Fang, F. Byfield, A. J. Travis, C. A. Vandenberg, G. H. Rothblat, and I. Levitan Cholesterol Sensitivity and Lipid Raft Targeting of Kir2.1 Channels Biophys. J., December 1, 2004; 87(6): 3850 - 3861. [Abstract] [Full Text] [PDF] |
||||
|
|